Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T13:01:13.297Z Has data issue: false hasContentIssue false

Results of 546 Blalock-Taussig shunts performed in 478 patients

Published online by Cambridge University Press:  19 August 2008

Khalid A. Al Jubair*
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Mohamed R. Al Fagih
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Abdullah S. Al Jarallah
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Saad Al Yousef
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
M.A. All Khan
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Abdullah Ashmeg
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Yahya Al Faraidi
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
William Sawyer
Affiliation:
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
*
Dr. Khalid Al Jubair, FRCS, Prince Sultan Cardiac Centre, PO Box 7897, Riyadh, 11159, Saudi Arabia. Tel: (01) 477 7714 ext 5229; (01) 476 0543

Abstract

Between 1983 and 1995, 546 Blalock-Taussig shunt procedures were performed in 472 patients: 128 (23.0%) were classical shunts, 90 of them on the same side as to the aortic arch, and 418 (77.0%) were modified shunts, 182 on the same side of the arch. At the time of surgery, 78 patients were aged below one week, 270 from one week to 12 months, and 198 patients were over one year of age. The mean pre-operative arterial saturation (71.7%±16.5%) was significantly increased to 83%±17.9% imme-diately after the procedure (p=0.017). The overall hospital mortality rate was 2.9% (16/546), with rates of 2.3% (3/128) for the classical, and 3.1% (13/418) for the modified shunts (p= not significant). The rate was significantly higher, however, for classical shunts when the pulmonary arterial diameter was less than 4 mm (15.4% versus zero; p=0.047), though this relationship was reversed for modified shunts (zero versus 3.6%; p=0.338). Early mortality was significantly influenced by the age at surgery, 5/78 (6.4%) in patients aged below 1 week, 3.7% between 1 week and 1 year, and 0.5% over 1 year (p=0.019). Early mortality was also significantly increased in patients weighing 3kg or less, 8/156 (5.1%), versus 3/303 (1.0%), p=0.037. Overall, 51 shunts failed (9–3%), 10 early and 41 late. Early failure was significantly increased in patients weighing 3kg or less, 8/156 (5.1%) versus 3/303 (1.0%), p=0.016. The overall early failure rate was 1.4% (3/215) when heparin was administered intra-operatively and for 48 hours postoperatively, in contrast to an early failure rate of 3.4% (7/203) when heparin was not used (p = 0.294). Overall rates of failure during follow-up were 9.1% (17/188) in heparinized patients versus!3.6% (24/177), (p=0.173) in non-heparinized patients. Failure of classical shunts was 10.2% (13/128), compared with 6.7% (28/418) for modified shunts (p=0.195). Failure was more common overall if the pulmonary arterial diameter was less than 4 mm, 14.7% (9/61), as opposed to 8.7% (26/300) when the diameter was 4 mm or greater, (p=0.144). Administration of aspirin during follow-up after the modified shunt procedure reduced failure from 11 % (18/163) to 6.7% (10/150), p=0.176. Classical or modified Blalock-Taussig shunts, either on the same side or opposite to the aortic arch, can be performed on patients of any age with minimum postoperative complications and low operative mortality. The use of intra- and post-operative heparin appears to reduce the overall rate of failure, and the administration of aspirin during follow-up appears to reduce failure of modified Blalock-Taussig shunts.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Blalock, A, Taussig, HB.Surgical treatment of malformations of the heart in which there is pulmonary stenosis or pulmonary atresia. JAMA 1945;128:189CrossRefGoogle Scholar
2.Wools, PK, Stephenson, LW, Meijboom, E.A comparison of Blalock-Taussig, Walterstone and Polytetrafluoroethylene shunts in children less than two weeks of age. Ann Thorac Surg 1984;38:26–29.Google Scholar
3.Ullon, RL, Sade, RM, Crawford, FA Jr. The Blalock-Taussig shunt in infants: standard versus modified. Ann Thorac Surg 1987;44:539–543.Google Scholar
4.Laks, H, Castaneda, AR.Subclavian arterial plasty for ipsilateral Blalock-Taussig shunt. Ann Thorac Surg 1973;19:319–321.Google Scholar
5.Guyton, RA, Owens, JE, Waumett, JD. The Blalock-Taussig shunt. Low risk, effective palliation and pulmonary artery growth. J Thorac Cardiovasc Surg 1989;85:917–922.Google Scholar
6.Arciniegas, E, Blackstone, EH, Pacifico, AD, Kirklin, JWClassic shunting operations as part of a two-stage repair for Tetralogy of Fallot. Ann Thorac Surg 1979;27:514–518.CrossRefGoogle ScholarPubMed
7.Edmunds, OH Jr., Stevenson, IW, Gadzik, JPThe Blalock-Taussig anastomosis in infants younger than one week of age. Circulation 1980;62:597–603.Google Scholar
8.Neches, WH, Naifeh, JG, Park, SC, Linox, CC, Zuberbuhler, JR, Siewers, RD.Systemic-pulmonary artery anastomosis in infancy. J Thorac Cardiovasc Surg 1975;70:91–927.Google Scholar
9.Aziz, KU, Olley, PM, Rowe, RD, Trussler, GA, Mustard, WT.Survival after systemic to pulmonary artery shunts in infants less than 30 days old with obstructive lesions of the right heart chambers. Ped Cardiol 1975;36:479–483.Google Scholar